These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


296 related items for PubMed ID: 3898762

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.
    Hollander PM, Asplin CM, Palmer JP.
    Diabetes; 1982 Jun; 31(6 Pt 1):489-95. PubMed ID: 6759265
    [Abstract] [Full Text] [Related]

  • 6. Insulin secretion in diabetes mellitus.
    Pfeifer MA, Halter JB, Porte D.
    Am J Med; 1981 Mar; 70(3):579-88. PubMed ID: 7011013
    [Abstract] [Full Text] [Related]

  • 7. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ, Prigeon RL, D'Alessio DA.
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of epinephrine on pancreatic beta-cell and alpha-cell function in patients with NIDDM.
    Ortiz-Alonso FJ, Herman WH, Zobel DL, Perry TJ, Smith MJ, Halter JB.
    Diabetes; 1991 Sep; 40(9):1194-202. PubMed ID: 1936624
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vivo beta-cell function at the transition to early non-insulin-dependent diabetes mellitus.
    Swinburn BA, Gianchandani R, Saad MF, Lillioja S.
    Metabolism; 1995 Jun; 44(6):757-64. PubMed ID: 7783660
    [Abstract] [Full Text] [Related]

  • 14. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [Abstract] [Full Text] [Related]

  • 15. Insulin secretion and insulin action in non-insulin-dependent diabetes mellitus: which defect is primary?
    Reaven GM.
    Diabetes Care; 1984 Jun; 7 Suppl 1():17-24. PubMed ID: 6376025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene.
    Herman WH, Fajans SS, Smith MJ, Polonsky KS, Bell GI, Halter JB.
    Diabetes; 1997 Nov; 46(11):1749-54. PubMed ID: 9356021
    [Abstract] [Full Text] [Related]

  • 18. Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.
    Hamada Y, Ikegami H, Ueda H, Kawaguchi Y, Yamato E, Nojima K, Yamada K, Babaya N, Shibata M, Ogihara T.
    Metabolism; 2001 Nov; 50(11):1282-5. PubMed ID: 11699045
    [Abstract] [Full Text] [Related]

  • 19. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA, Halter JB, Judzewitsch RG, Beard JC, Best JD, Ward WK, Porte D.
    Diabetes Care; 1984 Nov; 7 Suppl 1():25-34. PubMed ID: 6376026
    [Abstract] [Full Text] [Related]

  • 20. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
    Hamaguchi T, Fukushima H, Uehara M, Wada S, Shirotani T, Kishikawa H, Ichinose K, Yamaguchi K, Shichiri M.
    Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.